Transgenomic Sues Power3 for Libel, Slander, Breach of Contract in Protein Biomarker Deal
February 26, 2010
Transgenomic Sues Power3 for Libel, Slander, Breach of Contract in Protein Biomarker Deal
The lawsuit, filed this week in US District Court in Nebraska, stems from a deal signed last year to develop and commercialize Power3's biomarker tests for neurodegenerative diseases.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Power3 Asks Court to Dismiss Fraud Claim in Suit Filed by Transgenomic
April 16, 2010 / ProteoMonitor - Power3 Shareholders File Motion to Dismiss Insider Trading Lawsuit
June 4, 2010 / ProteoMonitor - Power3 Alleges Insider Trading by Two of its Largest Shareholders
May 7, 2010 / ProteoMonitor - Power3 Kills Deal to Buy StemTronix
May 7, 2010 / ProteoMonitor - Power3 Inks Parkinson's Protein Biomarker Deal with Amarantus, Looks to Enter CRO Space
January 30, 2012 / ProteoMonitor